scholarly journals A Three-year Follow Up Case with Severe Ischemic Heart Disease after Retrograde Catheter-based Autologous Bone Marrow Cells Implantation via the Coronary Vein

2010 ◽  
Vol 69 (3) ◽  
pp. 203-208
Author(s):  
Yasuo Watanabe ◽  
Tadateru Takayama ◽  
Takafumi Hiro ◽  
Shinichiro Yokoyama ◽  
Satoshi Kunimoto ◽  
...  
Keyword(s):  
Bone Marrow ◽  
Heart Disease ◽  
Ischemic Heart Disease ◽  
Bone Marrow Cells ◽  
Autologous Bone Marrow ◽  
Ischemic Heart ◽  
Coronary Vein ◽  
Autologous Bone ◽  
Marrow Cells

The Safety and Feasibility of the Local Implantation of Autologous Bone Marrow Cells for Ischemic Heart Disease

2003 ◽  
Vol 18 ◽  
pp. S69-S75 ◽  
Author(s):  
Tao-Sheng Li ◽  
Kimikazu Hamano ◽  
Ken Hirata ◽  
Toshiro Kobayashi ◽  
Masahiko Nishida
Keyword(s):  
Bone Marrow ◽  
Heart Disease ◽  
Ischemic Heart Disease ◽  
Bone Marrow Cells ◽  
Autologous Bone Marrow ◽  
Ischemic Heart ◽  
Autologous Bone ◽  
Marrow Cells

scholarly journals Local Implantation of Autologous Bone Marrow Cells for Therapeutic Angiogenesis in Patients With Ischemic Heart Disease

2001 ◽  
Vol 65 (9) ◽  
pp. 845-847 ◽  
Author(s):  
Kimikazu Hamano ◽  
Masahiko Nishida ◽  
Ken Hirata ◽  
Akihito Mikamo ◽  
Tao-Sheng Li ◽  
...  
Keyword(s):  
Bone Marrow ◽  
Heart Disease ◽  
Ischemic Heart Disease ◽  
Bone Marrow Cells ◽  
Autologous Bone Marrow ◽  
Therapeutic Angiogenesis ◽  
Ischemic Heart ◽  
Autologous Bone ◽  
Marrow Cells

Autologous Bone Marrow Cells for Treatment of Myocardial Infarction in Colombia.

Blood ◽  
2004 ◽  
Vol 104 (11) ◽  
pp. 4171-4171
Author(s):  
Francisco Cuéllar-Ambrosi ◽  
Juán Manuel ◽  
Oscar Velásquez ◽  
Margarita Velásquez-Lopera ◽  
Claudia Navas ◽  
...  
Keyword(s):  
Myocardial Infarction ◽  
Bone Marrow ◽  
Heart Disease ◽  
Bone Marrow Cells ◽  
Autologous Bone Marrow ◽  
Acute Mi ◽  
Autologous Bone ◽  
Stimulating Factor ◽  
Marrow Cells

Abstract Experimental studies in animals demonstrate the ability of the bone marrow stem cells to differentiate in cardiomyocytes, vascular endothelium cells and smooth muscle cells. There is evidence that these cells can regenerate infarcted myocardium and induce myogenesis and angiogenesis. Clinical studies in humans suggest the feasibility and safety of the utilization of the stem cells to recovery the ventricular function in patients with acute myocardial infarction. We report the first experience in Colombia using autologous bone marrow cells for cardiomyoplasty in isquemic heart disease. This report shows the two months follow-up of four patients, three with acute myocardial infarction of the anterior myocardial wall and one patient with severe chronic isquemic heart disease. Extensive myocardial damage demonstrated by absence of viability in scintigraphic images and ejection fraction less than 40%. The patients received an optimum postinfarction medical treatment, successful coronary percutaneous intervention (three patients) or direct intramyocardial injection (one patient) to transfer of autologous bone marrow cells mobilised with granulocyte-colony stimulating factor during five days. Demographics and results The exercise capacity improve importantly, evidenced by increase in contractility, the six minutes test, the treadmill exercise time and the functional capacity in METS. There were not changes in the myocardial perfusion at two months follow-up, there were not complications related to the cellular transplant or the utilization of the granulocyte-colony stimulating factor. This is the first experience in Colombia with the bone marrow cells and selective intracoronary transplantation for myocardial regeneration and angiogenesis. We observed functional recovery of the left ventricle, improvement in the exercise capacity without adverse effects or complications related to the therapy. Patient # 1 2 3 4 MI= myocardial infarction, IHD= isquemic heart disease, B/A= before/after 2 months, EF= eyection fraction, ESV=end systolic volume Age/sex 51/M 23/M 59/M 53/M Diagnosis acute MI acute MI acute MI chronic IHD Diagnosis to transplant 3 weeks 2 weeks 4 weeks > 1 year CD34 dose 19.7x10(6) 16.8x10(6) 19.5x10(6) 21.7x10(6) EF% B/A 36/43 26/40 40/41 45/55 ESV (cc) B/A 80/60 116/103 65/70 101/84 METS B/A 4/14 4/17 5/12 5/14 6-min test (mts) B/A 420/540 216/462 260/450 414/727

Treatment of osteonecrosis of the femoral head with implantation of autologous bone-marrow cells: Five-year follow-up

Bone ◽  
2007 ◽  
Vol 40 (6) ◽  
pp. S46-S47 ◽  
Author(s):  
V. Gangji ◽  
M. Toungouz ◽  
M. Lambermont ◽  
E. Bastianelli ◽  
J. Hauzeur
Keyword(s):  
Bone Marrow ◽  
Femoral Head ◽  
Bone Marrow Cells ◽  
Autologous Bone Marrow ◽  
Autologous Bone ◽  
Marrow Cells
Sign in / Sign up

Export Citation Format

Share Document